Jacques Dutrieux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jacques Dutrieux has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Didier Bouscary
Universite Paris Cite, INSERM, CNRS, Institut Cochin, Paris - France ; Hematology care unit and laboratory, AP-HP, Hopital Cochin, Paris - France
25 shared publications - Fathia Mami-Chouaib
INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine-University Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France
25 shared publications - Georges Bismuth
Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, Paris, France. Present address
25 shared publications - Justine Decroocq
Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie clinique, Hôpital Cochin, Paris, France
25 shared publications - Luca Simula
Univ. Paris-Cité, INSERM, CNRS, Institut Cochin, Paris, France
25 shared publications - Marianne Mangeney
Unité des Rétrovirus Endogènes et Eléments Rétroïdes des Eucaryotes Supérieurs, CNRS UMR 8122, Institut Gustave Roussy, Villejuif, France
25 shared publications
Latest Publications
- 24 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (30)
BRCA1-RAD51 homologous DNA repair pathway promotes HIV-1 reverse transcription
HIV-1 infection triggers multiple cellular pathways that modulate viral replication and may promote latency. Central to this process is the reverse transcription of the viral RNA into DNA and its integration into host chromatin, both processes being regulated by the cell. Emerging evidence suggests that homologous recombination (HR) proteins, especially RAD51, may influence both pre- and post-integration stages. In this study, we show that HIV-1 induces the rapid formation of RAD51 nuclear foci in a BRCA1/2-dependent manner, with RAD51 loading onto viral DNA immediately during reverse transcription. Using ChIP, imaging, and biochemical assays, we demonstrate that this process enhances viral infectivity and reverse transcription efficiency. Our findings reveal a previously unidentified cellular response that recruits repair factors to viral DNA, regulating reverse transcription and influencing viral DNA fate. This work uncovers a previously unknown role for RAD51 in modulating early HIV-1 replication, providing insights into host-virus interactions and potential therapeutic strategies.
- 24 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (30)
BRCA1-RAD51 homologous DNA repair pathway promotes HIV-1 reverse transcription
HIV-1 infection triggers multiple cellular pathways that modulate viral replication and may promote latency. Central to this process is the reverse transcription of the viral RNA into DNA and its integration into host chromatin, both processes being regulated by the cell. Emerging evidence suggests that homologous recombination (HR) proteins, especially RAD51, may influence both pre- and post-integration stages. In this study, we show that HIV-1 induces the rapid formation of RAD51 nuclear foci in a BRCA1/2-dependent manner, with RAD51 loading onto viral DNA immediately during reverse transcription. Using ChIP, imaging, and biochemical assays, we demonstrate that this process enhances viral infectivity and reverse transcription efficiency. Our findings reveal a previously unidentified cellular response that recruits repair factors to viral DNA, regulating reverse transcription and influencing viral DNA fate. This work uncovers a previously unknown role for RAD51 in modulating early HIV-1 replication, providing insights into host-virus interactions and potential therapeutic strategies.
- Open Access
- 24 December 2025
- Published by Springer Nature in Retrovirology
- Vol. 23 (1)
Strand-specific detection of cell-associated sense and antisense HIV-1 RNAs in splenocytes and PBMC from PLWH
Background: Variation in the level of cell-associated HIV-1 RNA is an important parameter followed in clinical trials focusing on HIV-1 infection, latency or reactivation. In addition to sense products, HIV-1 also expresses antisense products that can modulate HIV-1 replication, either positively through the antisense protein ASP or negatively through repressive noncoding antisense RNAs. Therefore, quantification of both sense and antisense HIV-1 products could provide key information for monitoring the dynamics of viral replication in vivo. While the ASP protein is difficult to detect even in vitro, antisense RNAs can be detected both in vitro and in vivo. The aim of this study was therefore to establish protocols for the specific quantification of sense and antisense transcription that can be applied in clinical studies. To this end, we developed strand-specific RT-PCR protocols allowing us to quantify individually sense and antisense RNAs in PLWH with B and non-B viruses. Results: We show that the two RTqPCR protocols can quantify standard HIV-1 sequences with good analytical parameters. We also demonstrate the strand specificity of the two protocols by showing that RNAs of the other orientation do not contaminate RNAs of one orientation during the PCR step and that the sense and antisense RT-qPCR protocols detect distinct populations of HIV-1 RNAs. We then compared the sensitivity of RT-qPCR and RT-ddPCR to quantify HIV-1 cell-associated RNAs and found that RT-ddPCR results in lower inter-sample variation or higher levels of detection than RT-qPCR. Finally, we show that the RT-ddPCR protocols efficiently quantify cell-associated HIV-1 sense and antisense RNAs not only in HIV-1-infected primary CD4 + T cells but also in spleen and blood samples from untreated HIV-1-infected individuals. Conclusions: This study demonstrates that HIV-1 antisense RNAs are expressed in spleen and blood of untreated HIV-1-infected individuals, of at least B and CRF02 subtypes, and that the level of antisense transcription can be significant and even predominant, as compared to sense transcription. These data, along with the protocols we described, will enable a more thorough analysis of HIV-1 sense and antisense expression dynamics in vivo, which could pave the way for novel strategies to control HIV-1 infection.
- 24 December 2025
- Published by Springer Nature in Retrovirology
- Vol. 23 (1)
Open AccessStrand-specific detection of cell-associated sense and antisense HIV-1 RNAs in splenocytes and PBMC from PLWH
Background: Variation in the level of cell-associated HIV-1 RNA is an important parameter followed in clinical trials focusing on HIV-1 infection, latency or reactivation. In addition to sense products, HIV-1 also expresses antisense products that can modulate HIV-1 replication, either positively through the antisense protein ASP or negatively through repressive noncoding antisense RNAs. Therefore, quantification of both sense and antisense HIV-1 products could provide key information for monitoring the dynamics of viral replication in vivo. While the ASP protein is difficult to detect even in vitro, antisense RNAs can be detected both in vitro and in vivo. The aim of this study was therefore to establish protocols for the specific quantification of sense and antisense transcription that can be applied in clinical studies. To this end, we developed strand-specific RT-PCR protocols allowing us to quantify individually sense and antisense RNAs in PLWH with B and non-B viruses. Results: We show that the two RTqPCR protocols can quantify standard HIV-1 sequences with good analytical parameters. We also demonstrate the strand specificity of the two protocols by showing that RNAs of the other orientation do not contaminate RNAs of one orientation during the PCR step and that the sense and antisense RT-qPCR protocols detect distinct populations of HIV-1 RNAs. We then compared the sensitivity of RT-qPCR and RT-ddPCR to quantify HIV-1 cell-associated RNAs and found that RT-ddPCR results in lower inter-sample variation or higher levels of detection than RT-qPCR. Finally, we show that the RT-ddPCR protocols efficiently quantify cell-associated HIV-1 sense and antisense RNAs not only in HIV-1-infected primary CD4 + T cells but also in spleen and blood samples from untreated HIV-1-infected individuals. Conclusions: This study demonstrates that HIV-1 antisense RNAs are expressed in spleen and blood of untreated HIV-1-infected individuals, of at least B and CRF02 subtypes, and that the level of antisense transcription can be significant and even predominant, as compared to sense transcription. These data, along with the protocols we described, will enable a more thorough analysis of HIV-1 sense and antisense expression dynamics in vivo, which could pave the way for novel strategies to control HIV-1 infection.
- Open Access
- 31 October 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (23) , 5826-5858
GABARAP proteins regulate the packaging of HIV-1 genomic RNA into virions
In addition to their role in canonical autophagy, autophagy proteins (ATG) contribute to various cellular processes, including phagocytosis, membrane remodeling, and vesicle secretion. Several viruses also exploit components of the autophagy pathway for their own replication. Here, we explore the role of ATG proteins in HIV-1 assembly. Postulating that host proteins crucial for virion assembly are present at the assembly site and can be incorporated within virions, we analyze the proteome of HIV-1 preparations using mass spectrometry. We identify an enrichment of macroautophagy-related terms, notably 3 of the 6 ATG8 (LC3/GABARAP) proteins. Functional studies reveal that GABARAP proteins are critical for the production of infectious virions. Knockout of GABARAP proteins reduces the packaging of viral genomic RNA (gRNA) into particles, impairing virion infectivity. GABARAPL1 associates with gRNA and interacts with Gag in an RNA-dependent manner. Additionally, GABARAP knockout increases cellular Gag:gRNA complexes and decreases gRNA association with membranes, suggesting that GABARAP proteins regulate gRNA fate during HIV-1 assembly by facilitating its packaging. This study uncovers a novel role for GABARAP proteins in HIV-1 genome packaging.
- 31 October 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (23) , 5826-5858
Open AccessGABARAP proteins regulate the packaging of HIV-1 genomic RNA into virions
In addition to their role in canonical autophagy, autophagy proteins (ATG) contribute to various cellular processes, including phagocytosis, membrane remodeling, and vesicle secretion. Several viruses also exploit components of the autophagy pathway for their own replication. Here, we explore the role of ATG proteins in HIV-1 assembly. Postulating that host proteins crucial for virion assembly are present at the assembly site and can be incorporated within virions, we analyze the proteome of HIV-1 preparations using mass spectrometry. We identify an enrichment of macroautophagy-related terms, notably 3 of the 6 ATG8 (LC3/GABARAP) proteins. Functional studies reveal that GABARAP proteins are critical for the production of infectious virions. Knockout of GABARAP proteins reduces the packaging of viral genomic RNA (gRNA) into particles, impairing virion infectivity. GABARAPL1 associates with gRNA and interacts with Gag in an RNA-dependent manner. Additionally, GABARAP knockout increases cellular Gag:gRNA complexes and decreases gRNA association with membranes, suggesting that GABARAP proteins regulate gRNA fate during HIV-1 assembly by facilitating its packaging. This study uncovers a novel role for GABARAP proteins in HIV-1 genome packaging.
- Open Access
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
AS1842856 treatment does not allow T cells proliferation.
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
AS1842856 treatment does not allow T cells proliferation.
- Open Access
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
AS1842856 promotes Tfh polarization.
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
AS1842856 promotes Tfh polarization.
- Open Access
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
CAR-TAS cells are more potent in vivo.
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
CAR-TAS cells are more potent in vivo.
- Open Access
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
Main characteristics of patients.
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
Main characteristics of patients.
- Open Access
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
CAR expression in non-activated cells after culture in presence of cytokines.
- 11 June 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
CAR expression in non-activated cells after culture in presence of cytokines.